Doyle Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$29.5M Sell
180,282
-1,438
-0.8% -$243K 2.53% 5
2022
Q2
$32.3M Sell
181,720
-1,042
-0.6% -$186K 2.6% 5
2022
Q1
$32.4M Buy
182,762
+1,041
+0.6% +$177K 2.33% 8
2021
Q4
$31.1M Buy
181,721
+1,634
+0.9% +$268K 2.23% 8
2021
Q3
$29.1M Buy
180,087
+1,001
+0.6% +$171K 2.31% 8
2021
Q2
$29.5M Buy
179,086
+3,400
+2% +$563K 2.45% 7
2021
Q1
$28.9M Sell
175,686
-261
-0.1% -$42.2K 2.76% 5
2020
Q4
$27.7M Buy
175,947
+4,672
+3% +$689K 2.82% 4
2020
Q3
$25.5M Buy
171,275
+1,649
+1% +$244K 2.96% 4
2020
Q2
$23.9M Sell
169,626
-2,237
-1% -$326K 3.14% 5
2020
Q1
$22.5M Buy
171,863
+1,654
+1% +$235K 3.58% 3
2019
Q4
$24.8M Buy
170,209
+5,315
+3% +$721K 3.1% 3
2019
Q3
$21.3M Buy
164,894
+3,759
+2% +$495K 2.95% 4
2019
Q2
$22.4M Sell
161,135
-108
-0.1% -$14.9K 3.1% 4
2019
Q1
$22.4M Buy
161,243
+2,101
+1% +$281K 3.26% 4
2018
Q4
$20.5M Buy
159,142
+41,454
+35% +$5.78M 3.47% 3
2018
Q3
$16.3M Sell
117,688
-1,323
-1% -$176K 2.53% 10
2018
Q2
$14.4M Buy
119,011
+4,925
+4% +$614K 2.38% 12
2018
Q1
$14.6M Buy
114,086
+1,536
+1% +$208K 2.46% 12
2017
Q4
$15.7M Sell
112,550
-5,003
-4% -$697K 2.66% 11
2017
Q3
$15.3M Sell
117,553
-1,604
-1% -$213K 2.68% 10
2017
Q2
$15.8M Sell
119,157
-36,157
-23% -$4.61M 2.92% 8
2017
Q1
$19.3M Buy
+155,314
New +$18.6M 3.94% 4

Other funds holding JNJ

Doyle Wealth Management's JNJ Position: Q3 2022 in Review

Doyle Wealth Management reduced its Johnson & Johnson (JNJ) stake by 0.79% in Q3 2022, selling an estimated $243K and leaving 180,282 shares worth $29.5M. The position accounts for 2.53% of the portfolio, ranked #5.

Doyle Wealth Management first reported a position in JNJ in Q1 2017 and has held it in 23 quarters since. The position peaked at $32.4M in Q1 2022. 3,623 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.

  • Doyle Wealth Management held 180,282 shares of Johnson & Johnson worth $29.5M as of Q3 2022.
  • Doyle Wealth Management sold 1,438 Johnson & Johnson shares in Q3 2022, an estimated $243K.
  • Johnson & Johnson made up 2.53% of Doyle Wealth Management's portfolio in Q3 2022, its #5 holding.
  • Doyle Wealth Management first reported a position in Johnson & Johnson in Q1 2017 and has held it in 23 quarters since.
  • Doyle Wealth Management's Johnson & Johnson position peaked at $32.4M in Q1 2022.
  • 3,623 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.

Based on Doyle Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.